Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Survival After Second Kidney Transplant: Are We Being Good Stewards?
C. Jay, J. Pugh, G. Halff, G. Abrahamian, F. Cigarroa, N. Stephens, K. Washburn.
University of Texas Health Science Center, San Antonio.
BACKGROUND: Primary kidney transplant is associated with increased life years compared with dialysis. Comparable patient survival between primary (1KT) and second kidney transplants (2KT) has…
2016 American Transplant Congress
A Successful Approach to Kidney Transplantation in Patients with Secondary Hyperoxaluria.
J. Roodnat,¹ A. Mik-van Egmond,² W. Visser,² S. Berger,³ W. van der Meijden,⁴ F. Knauf,⁵ M. Agteren van,¹ M. Betjes,¹ E. Hoorn.¹
¹Internal Medicine, Erasmus MC, Rotterdam, Netherlands; ²Dietetics, Erasmus MC, Rotterdam, Netherlands; ³Internal Medicine, University Hospital, Groningen, Netherlands; ⁴Internal Medicine, Radboud University, Nijmegen, Netherlands; ⁵Nephrology and Hypertension, Friedrich-Alexander-Universität, Erlangen-Nürnberg, Germany.
Chronic oxalate nephropathy is observed secondary to enteric hyperoxaluria that is associated with malabsorption e.g. in short bowel syndrome. Kidney transplantation can be challenging given…
2016 American Transplant Congress
Tacrolimus as a Tool for Intracellular Assessment of von Willebrand Factor Production by Activated Human Glomerular Endothelial Cells.
S. Béland, P. Vallin, O. Désy, S. De Serres.
Renal Division, University Health Center (CHU) of Quebec, Laval University, Quebec, QC, Canada.
Background: Von Willebrand factor (vWF) is a prothrombotic mediator stored in intracytoplasmic granules within endothelial cells and is released by endothelial exocytosis, leading to microangiopathic…
2016 American Transplant Congress
Pharmakokinetics of Prolonged-Release Formulation of Tacrolimus: Comparison of AUC0-24 and Concentration at 10 Time Points.
K. Unagami,¹ M. Okumi,² M. Furusawa,² T. Hirai,² T. Shimizu,² K. Omoto,² M. Inui,² H. Ishida,² K. Nitta,¹ K. Tanabe.²
¹Nephrology, Tokyo Women's Medical University, Tokyo, Japan; ²Urology, Tokyo Women's Medical University, Tokyo, Japan.
Background:Use of an appropriate immunosuppressant is necessary for good graft survival in kidney transplantation (KTx). Currently, a prolonged-release formulation of tacrolimus (Graceptor or Adovagraf, Astellas…
2016 American Transplant Congress
Will the New Kidney Allocation System Negatively Impact Future Organ Donation in States Mandated to Export a Large Number of Kidneys?
D. Mital,¹ E. Hull,¹ J. Brown,¹ C. Karmell,² M. Jendrisak.²
¹Kidney Transplant Program, General Surgery, Advocate Christ Medical Center, Oak Lawn, IL; ²Quality and Process Improvement, Gift of Hope OPO, Itasca, IL.
Purpose: To examine the potentially deleterious effects of the new Kidney Allocation System (KAS) on future organ donation: as a consequence of the massive increase…
2016 American Transplant Congress
Altruistic Kidney Donation: A Single US Transplant Center Experience.
A. Aguire-Alarcon,¹ M. Lubetzky,¹ M. McKinney,¹ L. Kayler.²
¹Transplantation, Albert Einstein College of Medicine, Bronx, NY; ²Transplantation, University of Buffalo, Buffalo, NY.
Background: Altruistic donors (ADs) continue to make rising contributions to the donor pool. Increasing efforts have been made to assess ADs to understand the motivations…
2016 American Transplant Congress
Hydrogen Sulfide Supplementation Helps Mitigate Effects of Ischemia Reperfusion Injury in a Murine Model of Donation After Cardiac Death Renal Transplantation.
J. Grewal,¹ I. Lobb,¹ M. Saha,² J. Jiang,² A. Haig,¹ A. Sener.^1,2
¹Microbiology & Immunology, University of Western Ontario, London, Canada; ²Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, Canada.
Donation after cardiac death(DCD) renal grafts experience a combination of prolonged warm and cold ischemia leading to greater ischemia reperfusion injury(IRI) that results in higher…
2016 American Transplant Congress
Single Center Experience with Robotic Kidney Transplantation for Recipients with BMI >40 kg/m²: A Comparison with the UNOS Registry.
I. Tvetanov, S. Garcia Aroz, M. Spaggiari, J. Hoonbae, J. Oberholzer, E. Benedetti.
Surgery, University of Illinois, Chicago, IL.
Introduction:Obesity represents a barrier to kidney transplantation, but the increasing prevalence amongst renal failure patients has forced some centers to carefully consider such candidates. Morbidly…
2016 American Transplant Congress
Effect of Telehealth Monitoring on Early Hospital Readmission After Renal Transplantation.
K. Noon,¹ N. Sarabu,¹ J. Augustine,¹ D. Hricik,¹ B. Deleva,¹ K. Woodside,² M. Aeder,¹ J. Foote,¹ A. Bruno,¹ K. Walsh,¹ M. Johnston,¹ V. Humphreville,¹ E. Sanchez.¹
¹University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH; ²University of Michigan, Ann Arbor, MI.
Introduction: Early hospital readmission (EHR) is an important quality metric of hospitals' performance. Kidney transplant surgery has a high EHR rate. It is not known…
2016 American Transplant Congress
Implementation of a Risk Stratified Approach for Prevention of Hepatitis B Reactivation Post Kidney Transplant.
M. Cote,¹ M. Pavlakis,² J. Ethridge,¹ C. Currier,² M. Curry,² E. Khankin,² F. Cardarelli,² K. Richards,^1,2 C. Rogers.^1,2
¹Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston; ²Transplant Institute, Beth Israel Deaconess Medical Center, Boston.
A large percentage of patients with end stage renal disease are known to be Hepatitis B virus (HBV) positive. A 2015 consensus guideline on use…